GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States... Show more
The 50-day moving average for GDRX moved above the 200-day moving average on August 22, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where GDRX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on August 18, 2025. You may want to consider a long position or call options on GDRX as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for GDRX just turned positive on August 18, 2025. Looking at past instances where GDRX's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GDRX advanced for three days, in of 256 cases, the price rose further within the following month. The odds of a continued upward trend are .
GDRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The 10-day RSI Indicator for GDRX moved out of overbought territory on August 19, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
GDRX moved below its 50-day moving average on August 20, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for GDRX crossed bearishly below the 50-day moving average on August 07, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GDRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for GDRX entered a downward trend on August 07, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GDRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.464) is normal, around the industry mean (11.767). P/E Ratio (50.667) is within average values for comparable stocks, (84.143). GDRX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (3.048). GDRX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.027). P/S Ratio (2.164) is also within normal values, averaging (96.645).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GDRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Industry ServicestotheHealthIndustry
A.I.dvisor indicates that over the last year, GDRX has been loosely correlated with CLSK. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if GDRX jumps, then CLSK could also see price increases.
Ticker / NAME | Correlation To GDRX | 1D Price Change % | ||
---|---|---|---|---|
GDRX | 100% | +1.56% | ||
CLSK - GDRX | 53% Loosely correlated | +5.25% | ||
RIOT - GDRX | 53% Loosely correlated | +7.74% | ||
COIN - GDRX | 51% Loosely correlated | +6.52% | ||
DBD - GDRX | 48% Loosely correlated | +2.82% | ||
COMP - GDRX | 48% Loosely correlated | +9.42% | ||
More |
Ticker / NAME | Correlation To GDRX | 1D Price Change % |
---|---|---|
GDRX | 100% | +1.56% |
Health Services category (437 stocks) | 19% Poorly correlated | +2.27% |
Services to the Health Industry category (94 stocks) | 8% Poorly correlated | +2.17% |